- US12390471utility2025Maytansinoid Derivatives with Self-immolative Peptide Linkers and Conjugates Thereof0 cites
- US11981687utility2024Methods of Preparing Cytotoxic Benzodiazepine Derivatives0 cites
- US11981688utility2024Methods of Preparing Cytotoxic Benzodiazepine Derivatives0 cites
- US11945862utility2024Compositions and Methods for Antibody Production0 cites
- US11932701utility2024Method for Increasing the Efficacy of Cancer Therapy by Administering an Anti-folr1 Immunoconjugate0 cites
- US11897961utility2024Anti-cd123 Antibodies and Conjugates and Derivatives Thereof0 cites
- US11833214utility2023Methods of Preparing Cell-binding Agent-drug Conjugates0 cites
- US11834498utility2023Biparatopic Fr-alpha Antibodies and Immunoconjugates0 cites
- US11793885utility2023Substituted Benzo[5,6][1,4]diazepino[1,2-a]indoles for the Treatment of Proliferative Disorders0 cites
- US11760759utility2023Process for Preparing Substituted Indolines0 cites
- US11744900utility2023Preparation of Maytansinoid Antibody Conjugates by a One-step Process0 cites
- US11732038utility2023Conjugates Comprising Cell-binding Agents and Cytotoxic Agents0 cites
- US11701428utility2023Therapeutic Combinations Comprising Anti-cd123 Immunoconjugates0 cites
- US11591296utility2023Methods of Preparing Cytotoxic Benzodiazepine Derivatives0 cites
- US11572349utility2023Selective Sulfonation of Benzodiazepine Derivatives0 cites
- USRE043899reissue2013Compositions and Methods for Treating Cancer Using Immunoconjugates and Chemotherapeutic Agents0 cites